Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000787 · ClinicalTrials.gov registry record · NA
Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT00000787: Completed NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00000787 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000787, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
PRIMARY: To identify factors associated with risk of HIV infection through heterosexual activity among urban, inner-city women. SECONDARY: To identify correlates of high-risk behaviors in order to provide a basis for future intervention studies.
Interventions
- BEHAVIORAL Pre- and post-test counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Phase | NA |
What the finished NCT00000787 record still lists
NCT00000787 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 1 intervention - of which Pre- and post-test counseling is the first listed.
NCT00000787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000787 about?
NCT00000787 is a clinical study titled "Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study". PRIMARY: To identify factors associated with risk of HIV infection through heterosexual activity among urban, inner-city women. SECONDARY: To identify correlates of high-risk behaviors in order to provide a basis for future intervention studies.
What is the current status of trial NCT00000787?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants.
What interventions are being tested in trial NCT00000787?
The interventions under investigation include: Pre- and post-test counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000787?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000787's enrollment target sits among peer trials
1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors